Advanced search
Publication Cover
Current Medical Research and Opinion Volume 32, 2016 - Issue 5
Submit an article Journal homepage
588
Views
5
CrossRef citations to date
0
Altmetric
Respiratory

Long-term (52 weeks) safety and tolerability of umeclidinium in Japanese patients with chronic obstructive pulmonary disease

Eiji YamagataYamagata Clinic, Oita, Japan;
,
Toru SoutomeBiomedical Data Sciences Department, GSK, Tokyo, Japan;
,
Kenichi HashimotoRespiratory Medicines Development, GSK, Tokyo, Japan; Correspondence[email protected]
,
Kazuko MiharaRespiratory Medicines Development, GSK, Tokyo, Japan;
&
Yuji TohdaDepartment of Respiratory Medicine and Allergology, Kinki University, Osaka, Japan
Pages 967-973 | Received 01 Sep 2015, Accepted 04 Jan 2016, Published online: 18 Feb 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Soichiro Hozawa, Hiroyuki Ohbayashi, Michiko Tsuchiya, Yu Hara, Laurie A Lee, Takashi Nakayama, Jun Tamaoki, Andrew Fowler & Takanobu Nishi. (2021) Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study. Journal of Asthma and Allergy 14, pages 809-819.
Read now
Andrea S. Melani & Piersante Sestini. (2016) Safety of long acting muscarinic antagonists: are all these drugs always and equally safe?. Current Medical Research and Opinion 32:5, pages 975-977.
Read now

Articles from other publishers (3)

Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Han Ni, Aung Htet & Soe Moe. (2017) Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2017:6.
Crossref
Joy Creaser-Thomas, Vignesh Rajasundaram & Gwyneth A Davies. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 161 171 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.